What You Should Know:
The U.S. digital therapeutics market size is estimated to reach $21.46B by 2030, expanding at a CAGR of 33.8% from 2023 to 2030, according to a new reports by Coherent Market…
Continue Reading
Top News
A science advisory group of the American Heart Association says that digital technology can address many of the challenges that are faced by center-based cardiac rehabilitation and care programs.
The authors list available…
Penn Medicine has introduced an AI chatbot named “Penny” to enhance cancer care. Patients exchanged nearly 4,000 medication-related text messages with Penny, with an accuracy rate of approximately 93%. Patient engagement for symptom assessment…
Continue Reading
At a time when emerging technologies are changing the role of human workers in so many industries, pharmacies are often stuck in an earlier era.
Despite the rise of digital tech, getting medication still mostly…
Mail order pharmacies like Mark Cuban Cost Plus Drug Company and Amazon’s RxPass are making prescription drugs more accessible and affordable. But there’s one thing these companies are missing: in-depth consultations with pharmacists, a…
Continue Reading
In 2022, CMS released the 2022 Final Rule that made remote therapeutic monitoring (RTM) a billable service for rehab therapists. RTM involves the collecting and monitoring of non-physiological data, such as pain duration or…
Continue Reading
Funding Will Grow Medication Adherence Services for Medicaid and Other Under-Resourced Populations
Scene Health, the leading medication engagement company, has closed an oversubscribed $17.7 million Series B growth financing led by ABS Capital Partners with participation from existing investors Claritas Health Ventures,…
Medication non-adherence costs the U.S. healthcare system more than $500 billion each year and can lead to unnecessary hospitalizations. One company is leveraging technology to change that.
Baltimore, Maryland-based Scene Health, formerly known as emocha,…
Why don’t we do what we’re “supposed to do” when it comes to our health?
Written by Matt Loper, Co-Founder and CEO at Wellth and originally posted on Wellth’s website.
I’ve seen so much unnecessary pain…
Previous articles in this series looked at barriers to taking medication and possible solutions, including special conditions that produce challenges. This final article in the series turns the question on its head. Can patients…
Continue Reading
